The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Apolipoprotein E polymorphism in health and disease
Abstract
Genetic polymorphism of apolipoprotein (apo) E is controlled by three common (epsilon 2, epsilon 2, epsilon 4) and several rare alleles (e.g., epsilon 1, epsilon 4*, epsilon 4v) at the apo E structural gene locus and may be demonstrated by isoelectric focusing of delipidated sera followed by immunoblotting. Apo E allele frequencies vary significantly between different ethnic groups. The common apo E isoforms E2 (arg158----cys) and E4 (cys112----arg) differ functionally from the parent E3 isoform, explaining their effects on the normal variance of plasma lipoprotein concentrations and their association with hyperlipidemic conditions. In all studied populations the receptor-binding defective apo E2 (arg158----cys) is associated with low cholesterol and apo B in heterozygotes and results in primary dysbetalipoproteinemia or type III hyperlipoproteinemia in homozygotes. Conversely, the epsilon 4 allele is associated with high cholesterol in Finns and Germans but less or not significantly so in Japanese or Singapore populations. In addition to their effects on the normal variance of lipoprotein concentrations, the alleles epsilon 2 and epsilon 4 are associated with hypertriglyceridemia and hypercholesterolemia, respectively. A working hypothesis explaining these observations is presented.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“More than 90% of patients with dysbetalipoproteinemia2 are apoE2 homozygotes.”
From Effects of the Absence of Apolipoprotein E on Lipoproteins, Neurocognitive Function, and Retinal Function (2014) · cites this paper as [2]
In the citing paper
“This suggests that type III HLP is a multifactorial disease-that is, additional factors, either genetic or environmental, are required for its phenotypic expression.7”
From Severe xanthomatosis associated with familial apolipoprotein E deficiency. (1996) · cites this paper as [7]
Citations
Cites
Plasma lipoproteins: apolipoprotein structure and function.
Mahley, R. W., Innerarity, T. L., Rall, S. C., & Weisgraber, K. H. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34443-6 · Cited by 1,155
Lipoprotein receptors and cholesterol homeostasis
Mahley, R. W., & Innerarity, T. L. (1983) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(83)90001-1 · Cited by 756
Human apolipoprotein E. The complete amino acid sequence
Rall, S. C., Weisgraber, K. H., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34702-1 · Cited by 741
(1985) · PubMed · Cited by 706
Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man
UTERMANN, G., HEES, M., & STEINMETZ, A. (1977) · Nature · doi:10.1038/269604a0 · Cited by 666
Self-citationLipoprotein receptors in the liver. Control signals for plasma cholesterol traffic.
Brown, M. S., & Goldstein, J. L. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111044 · Cited by 545
Polymorphism of apolipoprotein E
Utermann, G., Vogelberg, K. H., Steinmetz, A., Schoenborn, W., Pruin, N., Jaeschke, M., Hees, M. T. I. W. S.-V., & Canzler, H. (1979) · Clinical Genetics · doi:10.1111/j.1399-0004.1979.tb02027.x · Cited by 408
Self-citationEhnholm, C., Lukka, M., Kuusi, T., Nikkilä, E. A., & Utermann, G. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38833-7 · Cited by 403
Self-citationRall, S. C., Weisgraber, K. H., Innerarity, T. L., & Mahley, R. W. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.15.4696 · Cited by 345
Apolipoprotein E polymorphism and coronary artery disease.
Menzel, H. J., Kladetzky, R. G., & Assmann, G. (1983) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.3.4.310 · Cited by 344
(1981) · PubMed · Cited by 341
Utermann, G., Jaeschke, M., & Menzel, J. (1975) · FEBS Letters · doi:10.1016/0014-5793(75)81125-2 · Cited by 337
Self-citationSchneider, W. J., Kovanen, P. T., Brown, M. S., Goldstein, J. L., Utermann, G., Weber, W., Havel, R. J., Kotite, L., Kane, J. P., Innerarity, T. L., et al. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110330 · Cited by 310
Self-citationType III Hyperlipoproteinemia Associated with Apolipoprotein E Deficiency
Ghiselli, G., Schaefer, E. J., Gascon, P., & Breser, H. B. (1981) · Science · doi:10.1126/science.6795720 · Cited by 274
Polymorphism at the Apoprotein‐E locus in relation to risk of coronary disease
Cumming, A. M., & Robertson, F. W. (1984) · Clinical Genetics · doi:10.1111/j.1399-0004.1984.tb01995.x · Cited by 249
Apolipoprotein E phenotypes and hyperlipidemia
Utermann, G., Kindermann, I., Kaffarnik, H., & Steinmetz, A. (1984) · Human Genetics · doi:10.1007/bf00286508 · Cited by 238
Self-citationPolymorphism of Apolipoprotein E
Utermann, G. (1980) · Springer eBooks · doi:10.1007/978-1-4612-6071-4_131 · Cited by 212
Self-citationUtermann, G., Pruin, N., & Steinmetz, A. (1979) · Clinical Genetics · doi:10.1111/j.1399-0004.1979.tb02028.x · Cited by 209
Self-citationApolipoprotein E phenotyping from serum by Western blotting
Menzel, H., & Utermann, G. (1986) · Electrophoresis · doi:10.1002/elps.1150071103 · Cited by 174
Self-citationApolipoprotein E phenotypes in patients with myocardial infarction
Utermann, G., Hardewig, A., & Zimmer, F. (1984) · Human Genetics · doi:10.1007/bf00286509 · Cited by 150
Self-citationUtermann, G., Steinmetz, A., & Weber, W. (1982) · Human Genetics · doi:10.1007/bf00569216 · Cited by 149
Self-citationEhnholm, C., Mahley, R. W., Chappell, D. A., Weisgraber, K. H., Ludwig, E. H., & Witztum, J. L. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.17.5566 · Cited by 137
Failure of blood cardioplegia to protect myocardium at lower temperatures.
Gj, M., Flaherty, J. T., Vl, G., Bulkley, B. H., & Gardner, T. J. (1982) · PubMed · Cited by 113
Effects of apoprotein E polymorphism on serum lipoprotein concentration.
Robertson, F. W., & Cumming, A. (1985) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.5.3.283 · Cited by 81
Research works printed but not linked: 2
- Gregg, 1982, Abnormal metabolism of apolipoprotein E4, Circulation, 66, 160
- Ghiselli, 1981, Type III hyperlipoproteinemia associated with apolipoprotein E deficiency, Science, 214, 1239, 10.1126/science.6795720 · DOI · Paper page
Cited by
Sorted by citations
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
The mysteries of lipoprotein(a).
Utermann, G. (1989) · Science · doi:10.1126/science.2530631 · Cited by 1,257
Self-citationMouse Models of Diabetic Nephropathy
Brosius, F. C., Alpers, C. E., Böttinger, E. P., Breyer, M. D., Coffman, T. M., Gurley, S. B., Harris, R. C., Kakoki, M., Kretzler, M., Leiter, E. H., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009070721 · Cited by 901
Apolipoprotein E Polymorphism and Cardiovascular Disease: A HuGE Review
Eichner, J. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.6.487 · Cited by 796
Plasma triglyceride and coronary heart disease
Austin, M. A. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.1.2 · Cited by 697
Metadata
- Authors
- Utermann, G.
- Affiliations
- Universität Innsbruck (AT)
- Corresponding author
- Utermann, Gerd
- Venue
- American Heart Journal
- Publisher
- Elsevier BV
- Published
- 1987-02
- Volume
- 113
- Issue
- 2
- Pages
- 433-440
- ISSN
- 0002-8703 (ISSN-L)
- OpenAlex
- W2000991693
- Cited by
- 389
- References
- 24
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 4 · 2022: 2 · 2021: 4 · 2020: 4 · 2019: 2 · 2018: 4 · 2017: 1 · 2016: 3 · 2015: 2 · 2014: 12 · 2013: 4 · 2012: 3
- FWCI
- 22.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- apolipoprotein E, genetic polymorphism, apolipoprotein E2, APOE ε4, apolipoprotein E3, allele frequency, ethnic differences, hypertriglyceridemia, hypercholesterolemia, type III hyperlipoproteinemia, serum lipoproteins
- MeSH terms
- Alleles, Apolipoproteins E, Ethnicity, Gene Frequency, Humans, Hyperlipoproteinemia Type III, Polymorphism, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
